Serum carnitine and serum triglycerides were measured in 45 patients on CAPD and in 14 healthy controls. There was no significant difference between the mean carnitine levels in the two groups. Furthermore, there was no correlation between serum carnitine and serum triglycerides. Our data cast some doubt on the role of carnitine in the development of hypertriglyceridemia in patients on CAPD and on the need for carnitine supplementation in these patients.
Get full access to this article
View all access options for this article.
References
1.
RapoportJ., AvramM., ChannostizC., BrooksJ.G.Defective high density lipoprotein composition in patients on chronic hemodialysis.N Engl J Med1978; 229: 1326–1329.
BohmerT., BergremH., EklidK.Carnitine deficiency induced during intermittent hemodialysis for renal failure.Lancet1978; I: 126–128.
5.
BasileC., StanteC., LodesertoC.Effects of oral camitine administration on the lipid pattern during chronic hemodialysis.NVA1980; I: 126–129.
6.
AvliaJ., MasramonJ., LloverasJ.Llorach M, Andolz P. Carnitine in hemodialysis patients.Lancet1980; 2: 1028.
7.
BazzatoG., LucatelloS., LandiniS.Intraperitoneal (IP) L-carnitine administration: Successful therapeutic approach of hypertriglyceridemia in patients on double-bag system CAPD (abstract). II Int Symp on Perit Dial, Berlin. June 16-19, 1981.
8.
ParvinR., PandeS.V.Laboratory of intennediary metabolism.Clinical Research Institute of Montreal, Montreal.Canada.
9.
MitchellM.E.Carnitine metabolism in human subjects. I Nonnal metabolism.Am J Clin Nutr1978; 31: 293–306.
10.
MingardiG., BizziA., GiniM.Carnitine tolerance in hemodialysis patients.Clin Nephrol1980; 13: 269–270.
11.
ChanM.K., VargheseZ., PersaridJ.W., MoorheadJ.F.Carnitine in hemodialysis patients.Lancet1980; 2: 10281029.
12.
BazzatoG., MeezzinaC., CrmanM., GuarnierG.Myasthenia-Iike syndrome associated with carnitine in patients on long-tenn hemodialysis.Lancet1979; 1: 1041–1042.